New Key Statistics Module, Z-Score and F-Score
NAS:PTGX Key Ratios
Market Cap $ M | 2,028.78 |
Enterprise Value $ M | 1,742.38 |
P/E(ttm) | 14.18 |
PE Ratio without NRI | 14.18 |
Forward PE Ratio | 27.20 |
Price/Book | 3.62 |
Price/Sales | 7.05 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 314.00 |
EPS (TTM) $ | 2.44 |
Beneish M-Score | 339.22 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 1.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 11.57 |
EV-to-EBITDA | 11.32 |
PEG | 11.82 |
Shares Outstanding M | 58.65 |
Net Margin (%) | 51.47 |
Operating Margin % | 47.21 |
Pre-tax Margin (%) | 52.53 |
Quick Ratio | 15.72 |
Current Ratio | 15.72 |
ROA % (ttm) | 43.17 |
ROE % (ttm) | 47.41 |
ROIC % (ttm) | 223.46 |
Dividend Yield % | -- |
Altman Z-Score | 19.58 |
PTGX Number of Guru Trades
PTGX Volume of Guru Trades
Gurus Latest Trades with NAS:PTGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PTGX is held by these investors
Total 1
Protagonist Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PTGX
Total 0- 1